title: HIV and Zika: When will we be able to end these epidemics?
authors.affiliation: McGill University AIDS Centre, Jewish General Hospital, Montreal, QC, Canada. mark.wainberg@mcgill.ca.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Wainberg
authors.affiliation: Cambridge University, Cambridge, UK.
authors.forename: Andrew M L
authors.initials: AM
authors.lastname: Lever
mesh_terms: D044966:Anti-Retroviral Agents / Q000302:isolation & purification / Q000627:therapeutic use; D060740:Disease Eradication; D058872:Epidemics / Q000517:prevention & control*; D006678:HIV / Q000502:physiology; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D000072138:Mosquito Vectors / Q000821:virology; D014612:Vaccines / Q000302:isolation & purification; D000071244:Zika Virus / Q000502:physiology; D000071243:Zika Virus Infection / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D044966:Anti-Retroviral Agents; D014612:Vaccines